An interventional study of High intensity resistance exercise in PARKINSON DISEASE (Disorder), sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Parkinson Disease by University of Colorado, Denver — 8 open to participants now, 11 under way, none of them phase 3. Parkinson Disease · University of Colorado, Denver.
Among the 34 studies in Parkinson Disease by University of Colorado, Denver, this one is the 17th largest by planned enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2026, is one of 18 with no phase, reaches primary completion later than 10 of the 10 other live ones, and was the 34th registered.
4,581 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →8 of the 34 studies in Parkinson Disease by University of Colorado, Denver are open now, in 1 country. Recruiting first, the newest first:
University of Colorado, Denver · Sites in United States
Ages 45–75
University of Colorado, Denver · Sites in United States
Ages 45–85
University of Colorado, Denver · Sites in United States
Ages 18–65 · Healthy volunteers
University of Colorado, Denver · Sites in United States
Ages 18+
University of Colorado, Denver · Sites in United States
Ages 45–85
By country, each count listing its studies:
Of the 752 Parkinson Disease studies recruiting now, 313 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 1995; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 20 is below the median of 40 across 3,358 interventional studies indexed under Parkinson Disease.
Median enrollment 46 across the 24 interventional studies, 15 across the 10 observational. Of the 22 that completed or were terminated, 8 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Colorado, Denver is the lead sponsor of 1,547 studies on the registry; 318 are open to participants now.
Of its 147 completed or terminated interventional studies of FDA-regulated products, 92 (63%) have results posted.
3 of the studies in Parkinson Disease by University of Colorado, Denver that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06296810University of Colorado, DenverAdaptive DBS to Offset STN Dysregulation During Exercise in PD | 2026-12 |
| NCT04796506University of Colorado, DenverSlow Wave Sleep as a Biomarker of Rehabilitation-induced Cognitive Improvement in PD | 2027-05-31 |
| NCT06778135University of Colorado, DenverNeocortical Microarchitecture of Executive Function | 2027-10 |
Add all 3 to your calendar (.ics) → With an account.
Among the 34 studies in Parkinson Disease by University of Colorado, Denver, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to see the impact of 12 weeks of remote resistance exercise on remotely measured sleep quality for people with Parkinson's Disease.
This proof-of-concept study aims to evaluate the feasibility and acceptability of a 12-week remote high-intensity resistance exercise (rHIRE) intervention in people with PD and to assess its impact on real-world sleep quality. Participants will participate in three exercise sessions per week for 12 weeks. All exercise sessions will be completed over Zoom using the secure CU Anschutz Zoom account. After participants complete the strength assessments, they will be sent a link to the exercises, with descriptions and videos, which will be provided immediately before the first session via MedBridge, an online platform for home exercise programs. A neurologic physical therapist (PI) will virtually supervise the first week of exercise sessions. Exercises will be adjusted to make them easier or more difficult to find the exercise intensity at which the participant can complete 10 repetitions without form failure or an RPE above 7/10. During the second week of exercise sessions, the second session will be an assessment, where participants will complete the session under supervision but with no cueing or information from the supervisor. If the participant and the PI feel comfortable with the participant doing the session without supervision, they will transition to doing two sessions a week without supervision. The third session will be supervised and will focus on progression of intensity, checking form, and answering questions. If they do not feel ready, they will continue to be fully supervised until the next week, when the assessment will be completed again. Participants will fill out the Resistance Exercise Tracking Log each session, with or without supervision. They will be instructed to write the intensity of the exercises and their heart rate as recorded by the Fitbit.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: High intensity resistance exercise
Remote high intensity resistance training
Objective Sleep
Objective sleep will be measured using the Waveband sleep headband by measuring sleep efficiency (amount of time in bed is actually spent asleep), with a higher number being a better outcome
Time frame: Baseline and the week after completing the exercise intervention
Subjective Sleep
Subjective sleep will be measured using the Pittsburgh Sleep Quality Index (score from 0 to 21, the lower the score, the better the outcome)
Time frame: Baseline and the week after completing the exercise intervention
Started Oct 2026 (actual). Primary completion is estimated for Aug 2028, 21 months after the start.
Of 1,295 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 21 months is below that.
Counting every sponsor, half of 1,371 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Colorado, Denver →